Author:
Nesterova Maria,Stratakis Constantine A.
Reference154 articles.
1. Agrawal, S., Jiang, Z., Zhao Q, et al. (1997). Mixed-backbone oligonucleotides as second generation antisense oligonucleotides: in vitro and in vivo studies. Proc. Natl. Acad. Sci. U.S.A. 94:2620–2625.
2. Ally, S., Tortora, G., Clair, T., et al. (1988). Selective modulation of protein kinase isozymes by the site-selective analog 8-chloroadenosine 3′,5′-cyclic monophosphate provides a biological means for control of human colon cancer cell growth. Proc. Natl. Acad. Sci. U.S.A. 85:6319–6322.
3. Amieux, P.S., Cummings, D.E., Motamed, K., et al. (1997). Compensatory regulation of RI alpha protein levels in protein kinase A mutant mice. J. Biol. Chem. 272:3993–3998.
4. Beebe, S.J., and Corbin, J.D. (1986). Cyclic nucleotide-dependent protein kinases. In: Boyer, P.D., Krebs, E.G. (eds) The Enzymes: Control by Phosphorylation, Part A, vol 17. Academic Press, New York pp. 43–111.
5. Beebe, S.J., Øyen, O., Sandberg, M., et al. (1990). Molecular cloning of tissue-specific protein kinase (Cγ) from human testis representing a third isoform for the catalytic subunit of cAMP-dependent protein kinase. Mol. Endocrinol. 4:465–475.